Abbott Laboratories (ABT) — Hedge Fund Ownership Q4 2025
ABT
- Abbott Laboratories (ABT) is held by 6 of 82 tracked hedge funds, with Jensen Investment Management (4%) and Polen Capital Management (2%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in ABT holdings came from Polen Capital Management (-47%) and Jensen Investment Management (-22%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to Abbott Laboratories (ABT) by -38% vs the prior quarter and -53% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Jensen Investment Management
|
3.69% | 1.9M | -22.26% | +1711.86% | $234.7M | $125.29 | — |
| 2 |
Polen Capital Management
|
2.12% | 4.0M | -46.61% | -68.77% | $496.4M | $125.29 | — |
| 3 |
Mairs & Power
|
0.85% | 708K | -2.05% | -34.25% | $88.7M | $125.29 | — |
| 4 |
Torray Investment Partners Robert Torray
|
0.03% | 2K | — | — | $225,522 | $125.29 | — |
| 5 |
Gardner Russo & Quinn Thomas Russo
|
0.02% | 12K | — | — | $1.4M | $125.29 | — |
| 6 |
Dodge & Cox
|
0.00% | 17K | — | -2.98% | $2.2M | $125.29 | — |
| 6 | Total | — | 6.6M | -37.88% | -52.70% | $823.7M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.